News - UF Innovate

New Medicinal Plants Course Addresses Industry Needs

Emerging industries require a skilled workforce to function. Sometimes, the industry begins to boom before employers can hire a sufficient number of skilled employees. That was the case for many employers in the medicinal plant industry, which includes crops like hemp, kava and kratom. Faculty from two University of Florida colleges worked together to help meet that demand with a new course.

NSF Director: Let’s Seize This Moment To Achieve Prosperity for All

The Honorable Sethuraman Panchanathan, director of the National Science Foundation, visited the University of Florida on Friday, May 27, to learn more about UF’s research initiatives and share his vision for accelerating scientific advancements to benefit all. He is interviewed by guest host, David Norton, vice president for research at the University of Florida.

Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District

Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company. The site will be located adjacent to Lacerta Therapeutics' current location in Alachua, Florida, in Copeland Park, which Lacerta has occupied since 2020.

UF Scientist Helps Perfect Tool To Reduce Invasive Species Worldwide

A University of Florida scientist is working with a global research team to help control plants, animals and fish before they become invasive. To do this, resource managers first need protocols.

Confounding Pirates and Trojan Horses: AI Gatekeepers at UF Provide Innovative Tool for Industries Looking To Shut Down Bad Actors

Director of the Florida Institute for National Security and associate professor in the Department of Electrical and Computer Engineering, Dr. Woodard is leading a $1.2 million, three-year NSF research project to use artificial intelligence for the purpose of hardware security by developing an automated toolkit that will detect intellectual property and verify that the IC designs are exactly what they are supposed to be and not a piracy or sabotage.

Chemist Who Explores Cells’ Protein Interactions With Light To Join UF Scripps Biomedical Research

Promising new drugs sometimes fail when they reach clinical trials despite strong early data. A new scientist joining UF Scripps Biomedical Research aims to address this problem with new chemistry tools that map interactions within cells.

Sea Turtle Conservation Gets Boost From New DNA Detection Method

A study led by University of Florida researchers is the first to sequence environmental DNA, or eDNA, from sea turtles — genetic material shed as they travel over beaches and in water. The research project is also the first to successfully collect animal eDNA from beach sand. The techniques could be used to trace and study other kinds of wildlife, advancing research and informing conservation strategies.

UF Scripps Scientists To Receive $15 Million To Help Fight Current and Future Pandemics

Multiple scientists from UF Scripps Biomedical Research will join a massive federal effort to develop antiviral drugs to treat the pandemic coronavirus and other viral threats.

Shoulder Surgeons Perform First U.S. Surgeries Using Exactech’s Next Generation Cage Glenoid

UF Startup Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced successful first surgeries using the Equinoxe® Laser Cage Glenoid, an innovative, next-generation shoulder implant designed to improve glenoid fixation in anatomic total shoulder arthroplasty.

Myrtelle Enters Into a Worldwide Exclusive License Agreement With Rescue Hearing To Develop and Commercialize Gene Therapy for the Treatment of Hearing Loss

Myrtelle Inc., a clinical stage gene therapy company focused on developing transformative treatments for rare genetic diseases, today announced that it has entered into a worldwide exclusive licensing agreement with UF Innovate | Accelerate at The Hub alum Rescue Hearing Inc. (RHI) to develop a novel gene therapy for DFNB8 genetic hearing loss.

UF News